See more : Woolworths Holdings Limited (WHL.JO) Income Statement Analysis – Financial Results
Complete financial analysis of Gold Flora Corporation (GRAM.NE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Gold Flora Corporation, a leading company in the Tobacco industry within the Consumer Defensive sector.
- Gladstone Capital Corporation (GLAD) Income Statement Analysis – Financial Results
- Kovai Medical Center and Hospital Limited (KOVAI.BO) Income Statement Analysis – Financial Results
- Ålandsbanken Abp (ALBAV.HE) Income Statement Analysis – Financial Results
- Dexin Corporation (3349.TWO) Income Statement Analysis – Financial Results
- Xintela AB (publ) (XINT.ST) Income Statement Analysis – Financial Results
Gold Flora Corporation (GRAM.NE)
About Gold Flora Corporation
Gold Flora Corporation engages in the cultivation, manufacturing, extraction, distribution, and retailing of cannabis products in California. It offers disposable vape pens and gold flora flowers. The company was founded in 2017 and is based in Costa Mesa, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 90.96M | 63.06M | 79.22M | 0.00 | 0.00 |
Cost of Revenue | 58.49M | 54.23M | 88.56M | 0.00 | 0.00 |
Gross Profit | 32.47M | 8.83M | -9.34M | 0.00 | 0.00 |
Gross Profit Ratio | 35.70% | 14.00% | -11.79% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 50.87M | 18.32M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 2.72M | 919.00K | 0.00 | 0.00 | 0.00 |
SG&A | 53.59M | 18.83M | 147.65M | 9.28M | 563.70K |
Other Expenses | 25.63M | 1.27M | 0.00 | 0.00 | 0.00 |
Operating Expenses | 79.22M | 18.83M | 147.65M | 9.28M | 563.70K |
Cost & Expenses | 137.71M | 73.06M | 236.21M | 9.28M | 563.70K |
Interest Income | 0.00 | 812.35K | 1.23M | 2.47M | 5.39M |
Interest Expense | 19.64M | 20.71M | 5.11M | 0.00 | 0.00 |
Depreciation & Amortization | 13.16M | 8.07M | 22.24M | 206.30K | 202.63M |
EBITDA | 279.00K | -1.93M | -472.95M | -6.81M | -6.32M |
EBITDA Ratio | 0.31% | -3.06% | -170.09% | 0.00% | 0.00% |
Operating Income | -46.75M | -10.00M | -156.99M | -9.28M | -563.69K |
Operating Income Ratio | -51.39% | -15.87% | -198.17% | 0.00% | 0.00% |
Total Other Income/Expenses | 14.22M | -19.44M | -343.31M | 2.47M | -5.76M |
Income Before Tax | -32.52M | -15.62M | -500.30M | -6.81M | -6.32M |
Income Before Tax Ratio | -35.75% | -24.77% | -631.52% | 0.00% | 0.00% |
Income Tax Expense | 10.14M | 5.05M | -6.36M | -6.81M | -171.86K |
Net Income | -42.62M | -20.48M | -581.89M | 0.00 | -6.32M |
Net Income Ratio | -46.85% | -32.48% | -734.51% | 0.00% | 0.00% |
EPS | -0.23 | -0.22 | -6.12 | 0.00 | -0.43 |
EPS Diluted | -0.23 | -0.22 | -6.12 | 0.00 | -0.43 |
Weighted Avg Shares Out | 188.39M | 94.54M | 95.01M | 15.22M | 14.54M |
Weighted Avg Shares Out (Dil) | 188.39M | 94.54M | 95.01M | 15.22M | 14.54M |
Source: https://incomestatements.info
Category: Stock Reports